ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS
Article
Fisher, Barbara, Zhang, Peixin, Macdonald, David et al. (2018). ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS
. NEURO-ONCOLOGY, 20(suppl_6), vi11-vi11. 10.1093/neuonc/noy148.039
Fisher, Barbara, Zhang, Peixin, Macdonald, David et al. (2018). ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS
. NEURO-ONCOLOGY, 20(suppl_6), vi11-vi11. 10.1093/neuonc/noy148.039